• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Newly marketed medications present unique challenges for nonrandomized comparative effectiveness analyses.

作者信息

Rassen Jeremy A, Schneeweiss Sebastian

机构信息

Division of Pharmacoepidemiology & Pharmacoeconomics, Department of Medicine, Brigham & Women's Hospital & Harvard Medical School, Boston, MA, USA.

出版信息

J Comp Eff Res. 2012 Mar;1(2):109-11. doi: 10.2217/cer.12.12.

DOI:10.2217/cer.12.12
PMID:24237367
Abstract
摘要

相似文献

1
Newly marketed medications present unique challenges for nonrandomized comparative effectiveness analyses.新上市的药物给非随机对照有效性分析带来了独特的挑战。
J Comp Eff Res. 2012 Mar;1(2):109-11. doi: 10.2217/cer.12.12.
2
Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development.评估新上市药物的比较疗效：方法学挑战及对药物开发的影响。
Clin Pharmacol Ther. 2011 Dec;90(6):777-90. doi: 10.1038/clpt.2011.235. Epub 2011 Nov 2.
3
Comparative effectiveness studies of medications.药物的比较疗效研究。
Curr Opin Investig Drugs. 2010 Sep;11(9):987-8.
4
GRACE principles: recognizing high-quality observational studies of comparative effectiveness.GRACE 原则：识别高质量的比较有效性观察性研究。
Am J Manag Care. 2010 Jun;16(6):467-71.
5
Comparative effectiveness.比较效果
Trustee. 2010 Jan;63(1):13-4, 19-21.
6
Comparative effectiveness research: guidelines for good practices are just the beginning.比较效果研究：良好实践指南仅仅是个开始。
Expert Rev Pharmacoecon Outcomes Res. 2011 Feb;11(1):51-7. doi: 10.1586/erp.10.93.
7
Methodological issues in comparative effectiveness research: clinical trials.比较有效性研究中的方法学问题：临床试验。
Am J Med. 2010 Dec;123(12 Suppl 1):e8-15. doi: 10.1016/j.amjmed.2010.10.003.
8
Conducting comparative effectiveness research on medications: the views of a practicing epidemiologist from the other Washington.开展药物的比较疗效研究：来自另一个华盛顿的执业流行病学家的观点
Value Health. 2012 Mar-Apr;15(2):394-6. doi: 10.1016/j.jval.2011.08.1740. Epub 2011 Nov 9.
9
Comparative effectiveness research in oncology methodology: observational data.肿瘤学方法中的比较疗效研究：观察性数据。
J Clin Oncol. 2012 Dec 1;30(34):4215-22. doi: 10.1200/JCO.2012.41.6701. Epub 2012 Oct 15.
10
Methodological challenges of comparative effectiveness research in pain: implications for investigators, clinicians, and policy makers.疼痛领域比较效果研究的方法学挑战：对研究者、临床医生和政策制定者的启示
J Pain Palliat Care Pharmacother. 2011;25(3):267-74. doi: 10.3109/15360288.2011.599482.

引用本文的文献

1
Abemaciclib treatment patterns and outcome in HR+/HER2- locally advanced or metastatic breast cancer: a real-world study from Kuwait and Lebanon.阿贝西利治疗激素受体阳性/人表皮生长因子受体2阴性局部晚期或转移性乳腺癌的模式及疗效：科威特和黎巴嫩的一项真实世界研究
Front Oncol. 2025 Jun 17;15:1437380. doi: 10.3389/fonc.2025.1437380. eCollection 2025.
2
Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine.抗降钙素基因相关肽单克隆抗体在老年偏头痛患者或残疾成年偏头痛患者中的心血管安全性。
JAMA Neurol. 2025 Feb 1;82(2):132-141. doi: 10.1001/jamaneurol.2024.4537.
3
Abemaciclib for the Treatment of HR+HER2- Metastatic Breast Cancer: An Institutional Experience.
阿贝西利治疗激素受体阳性人表皮生长因子受体2阴性转移性乳腺癌：一项机构经验。
Cancers (Basel). 2024 May 10;16(10):1828. doi: 10.3390/cancers16101828.
4
Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2- Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice.在常规临床实践中接受阿贝西利治疗的主要为老年HR+/HER2-转移性乳腺癌患者的临床和人口统计学特征、治疗模式及结局的真实世界分析
Drugs Real World Outcomes. 2023 Dec;10(4):589-603. doi: 10.1007/s40801-023-00391-1. Epub 2023 Sep 29.
5
Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR + , HER2- metastatic breast cancer patients in Japan.在日本，真实世界中 abemaciclib 治疗 HR + 、HER2-转移性乳腺癌患者的治疗模式和结局。
Breast Cancer. 2023 Jul;30(4):657-665. doi: 10.1007/s12282-023-01461-6. Epub 2023 May 22.
6
Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2- Metastatic Breast Cancer Treated with Abemaciclib.使用阿贝西利治疗的HR +、HER2 - 转移性乳腺癌美国患者的真实世界患者特征、使用模式及结局
Drugs Real World Outcomes. 2022 Dec;9(4):681-693. doi: 10.1007/s40801-022-00327-1. Epub 2022 Sep 12.
7
Current use of routinely collected health data to complement randomized controlled trials: a meta-epidemiological survey.利用常规收集的健康数据补充随机对照试验的现状：一项元流行病学调查。
CMAJ Open. 2016 Apr 6;4(2):E132-40. doi: 10.9778/cmajo.20150036. eCollection 2016 Apr-Jun.
8
On the use of propensity scores in case of rare exposure.罕见暴露情况下倾向得分的应用。
BMC Med Res Methodol. 2016 Mar 31;16:38. doi: 10.1186/s12874-016-0135-1.